These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25112199)

  • 1. Fluorescent dye ProteoStat to detect and discriminate intracellular amyloid-like aggregates in Escherichia coli.
    Navarro S; Ventura S
    Biotechnol J; 2014 Oct; 9(10):1259-66. PubMed ID: 25112199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systems.
    Navarro S; Carija A; Muñoz-Torrero D; Ventura S
    Eur J Med Chem; 2016 Oct; 121():785-792. PubMed ID: 26608003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-like properties of bacterial inclusion bodies.
    Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S
    J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Protein Aggregation in Cells Using Fluorescent Labels Coupled to Flow Cytometry.
    Ventura S; Navarro S
    Methods Mol Biol; 2019; 1873():195-212. PubMed ID: 30341611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
    Villar-Piqué A; Espargaró A; Ventura S; Sabate R
    Biotechnol J; 2016 Jan; 11(1):172-7. PubMed ID: 26580000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation.
    Espargaró A; Sabate R; Ventura S
    Mol Biosyst; 2012 Nov; 8(11):2839-44. PubMed ID: 22868714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloids in bacterial inclusion bodies.
    de Groot NS; Sabate R; Ventura S
    Trends Biochem Sci; 2009 Aug; 34(8):408-16. PubMed ID: 19647433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethine cyanine dyes as fluorescent probes for amyloid fibrils: The effect of N,N'-substituents.
    Kuperman MV; Chernii SV; Losytskyy MY; Kryvorotenko DV; Derevyanko NO; Slominskii YL; Kovalska VB; Yarmoluk SM
    Anal Biochem; 2015 Sep; 484():9-17. PubMed ID: 25963892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of amyloid fibrils using size exclusion chromatography coupled with online fluorescence and ultraviolet detection.
    Randrianjatovo-Gbalou I; Marcato-Romain CE; Girbal-Neuhauser E
    Anal Biochem; 2015 Nov; 488():19-21. PubMed ID: 26239215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prion-like RNA-processing protein HNRPDL forms inherently toxic amyloid-like inclusion bodies in bacteria.
    Navarro S; Marinelli P; Diaz-Caballero M; Ventura S
    Microb Cell Fact; 2015 Jul; 14():102. PubMed ID: 26160665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies.
    González-Montalbán N; Villaverde A; Aris A
    Biochem Biophys Res Commun; 2007 Apr; 355(3):637-42. PubMed ID: 17307135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies.
    Hamodrakas SJ
    FEBS J; 2011 Jul; 278(14):2428-35. PubMed ID: 21569208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological role of bacterial inclusion bodies: a model for amyloid aggregation.
    García-Fruitós E; Sabate R; de Groot NS; Villaverde A; Ventura S
    FEBS J; 2011 Jul; 278(14):2419-27. PubMed ID: 21569209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Conversion of an Enzyme from Native-like to Amyloid-like Aggregates within Inclusion Bodies.
    Elia F; Cantini F; Chiti F; Dobson CM; Bemporad F
    Biophys J; 2017 Jun; 112(12):2540-2551. PubMed ID: 28636911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors.
    Pouplana S; Espargaro A; Galdeano C; Viayna E; Sola I; Ventura S; Muñoz-Torrero D; Sabate R
    Curr Med Chem; 2014; 21(9):1152-9. PubMed ID: 24059241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and thermodynamic stability of bacterial intracellular aggregates.
    Espargaró A; Sabaté R; Ventura S
    FEBS Lett; 2008 Oct; 582(25-26):3669-73. PubMed ID: 18840434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregation: folding aggregates, inclusion bodies and amyloid.
    Fink AL
    Fold Des; 1998; 3(1):R9-23. PubMed ID: 9502314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids.
    Wasmer C; Benkemoun L; Sabaté R; Steinmetz MO; Coulary-Salin B; Wang L; Riek R; Saupe SJ; Meier BH
    Angew Chem Int Ed Engl; 2009; 48(26):4858-60. PubMed ID: 19472238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein.
    Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM
    Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.